Filing Details
- Accession Number:
- 0001144204-16-120761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-23 16:14:19
- Reporting Period:
- 2016-08-22
- Filing Date:
- 2016-08-23
- Accepted Time:
- 2016-08-23 16:14:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1268135 | Arthur Przybyl | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-22 | 24,705 | $6.36 | 200,788 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-08-22 | 15,723 | $6.36 | 216,511 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-08-22 | 12,750 | $33.00 | 229,261 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-22 | 37,455 | $66.97 | 191,806 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Acquisiton | 2016-08-22 | 24,705 | $6.36 | 24,705 | $6.36 |
| Common Stock | Stock Options | Acquisiton | 2016-08-22 | 15,723 | $6.36 | 15,723 | $6.36 |
| Common Stock | Stock Options | Acquisiton | 2016-08-22 | 12,750 | $33.00 | 12,750 | $33.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,682 | 2013-07-11 | 2023-07-11 | No | 4 | M | Direct |
| 23,959 | 2013-07-11 | 2023-07-11 | No | 4 | M | Direct |
| 12,750 | 2014-03-31 | 2024-03-31 | No | 4 | M | Direct |
Footnotes
- The reported price is a weighted average sale price for multiple sale transactions ranging from a low sale price of $66.70 to a high sale price of $67.57. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request from the staff of the Securities and Exchange Commission, the Issuer or a stockholder of the Issuer.
Billionaire Hedge Funds
